D. E. Shaw & Co., Inc. TONIX PHARMACEUTICALS HLDG C Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
N/A
-5,009,843 Closed
0 $0
Q1 2022

May 16, 2022
SELL
N/A
-13,670,856 Reduced 73.18%
5,009,843 $1.15 Million
Q4 2021

Feb 14, 2022
BUY
N/A
11,989,832 Added 179.2%
18,680,699 $6.68 Million
Q3 2021

Nov 15, 2021
BUY
N/A
5,939,570 Added 790.58%
6,690,867 $4.02 Million
Q2 2021

Aug 16, 2021
BUY
N/A
751,297 New
751,297 $834,000
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email